A Trial to Reduce Readmissions Using Motivational Interviewing and Interactive Voice Response
A Hospital-based Intervention Using Motivational Interviewing and Interactive Voice Response to Reduce Readmissions in Congestive Heart Failure and Chronic Obstructive Pulmonary Disease Patients: A Randomized Controlled Trial
1 other identifier
interventional
512
1 country
2
Brief Summary
The primary purpose of this study is to determine the effectiveness of a hospital-based intervention, using motivational interviewing and interactive voice response (IVR), to reduce hospital readmissions within 90 days of enrollment compared to usual care, for patients with heart failure and chronic obstructive pulmonary disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jun 2010
Typical duration for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2013
CompletedFirst Submitted
Initial submission to the registry
May 10, 2013
CompletedFirst Posted
Study publicly available on registry
May 16, 2013
CompletedMay 16, 2013
May 1, 2013
2.6 years
May 10, 2013
May 13, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Hospital readmission rate (all cause)
Readmissions within 90 days from discharge of the index admission, for any diagnosis
90 days
Secondary Outcomes (4)
Emergency department visit rate (all cause)
90 days
Hospital days (all cause)
90 days
Mortality
90 days
Patient Activation Measure (PAM) score
90 days
Other Outcomes (1)
Days compliant with interactive voice response system (treatment group only)
30 days
Study Arms (2)
MI + IVR
EXPERIMENTAL90 days of motivational interviewing and 30 days of interactive voice response monitoring
Usual Care
NO INTERVENTIONUsual care that a patient would receive absent the intervention
Interventions
Participants in the intervention group received motivational interviewing from a registered nurse who is trained and proficient in this behavioral change modality. In addition, participants were instructed to make a daily toll-free call to an automated interactive voice response (IVR) system provided by Pharos Innovations® (Chicago, IL) for 30 days after discharge from the index admission. On each call patients heard a pre-recorded voice that goes through a series of questions about symptoms and the patient's daily weight. Information from the IVR system was automatically downloaded to a secure Internet site for review by the nurse at each hospital location.
Eligibility Criteria
You may qualify if:
- Age 18 years or older
- Index hospitalization for congestive heart failure or chronic obstructive pulmonary disease
- Access to telephone
You may not qualify if:
- Cognitive impairment
- Resident of a nursing home
- Does not speak English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Asante Three Rivers Medical Center
Grants Pass, Oregon, 97527, United States
Asante Rogue Regional Medical Center
Medford, Oregon, 97504, United States
Related Publications (1)
Linden A, Butterworth S. A comprehensive hospital-based intervention to reduce readmissions for chronically ill patients: a randomized controlled trial. Am J Manag Care. 2014 Oct;20(10):783-92.
PMID: 25365681DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Ariel Linden, DrPH
Linden Consulting Group, LLC
- STUDY DIRECTOR
Debra Flickinger, BS
Asante Health System
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- President, Linden Consulting Group, LLC
Study Record Dates
First Submitted
May 10, 2013
First Posted
May 16, 2013
Study Start
June 1, 2010
Primary Completion
January 1, 2013
Study Completion
January 1, 2013
Last Updated
May 16, 2013
Record last verified: 2013-05